1. Home
  2. RBOT vs GNLX Comparison

RBOT vs GNLX Comparison

Compare RBOT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBOT
  • GNLX
  • Stock Information
  • Founded
  • RBOT 2014
  • GNLX 2001
  • Country
  • RBOT United States
  • GNLX United States
  • Employees
  • RBOT N/A
  • GNLX N/A
  • Industry
  • RBOT Medical Specialities
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBOT Health Care
  • GNLX Health Care
  • Exchange
  • RBOT Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • RBOT 86.1M
  • GNLX 85.0M
  • IPO Year
  • RBOT N/A
  • GNLX 2023
  • Fundamental
  • Price
  • RBOT $13.01
  • GNLX $4.31
  • Analyst Decision
  • RBOT Hold
  • GNLX Strong Buy
  • Analyst Count
  • RBOT 2
  • GNLX 4
  • Target Price
  • RBOT $10.25
  • GNLX $18.25
  • AVG Volume (30 Days)
  • RBOT 38.9K
  • GNLX 314.9K
  • Earning Date
  • RBOT 03-03-2025
  • GNLX 03-31-2025
  • Dividend Yield
  • RBOT N/A
  • GNLX N/A
  • EPS Growth
  • RBOT N/A
  • GNLX N/A
  • EPS
  • RBOT N/A
  • GNLX N/A
  • Revenue
  • RBOT N/A
  • GNLX $8,000.00
  • Revenue This Year
  • RBOT N/A
  • GNLX N/A
  • Revenue Next Year
  • RBOT N/A
  • GNLX N/A
  • P/E Ratio
  • RBOT N/A
  • GNLX N/A
  • Revenue Growth
  • RBOT N/A
  • GNLX N/A
  • 52 Week Low
  • RBOT $4.27
  • GNLX $1.60
  • 52 Week High
  • RBOT $19.00
  • GNLX $9.82
  • Technical
  • Relative Strength Index (RSI)
  • RBOT 51.16
  • GNLX 75.11
  • Support Level
  • RBOT $12.34
  • GNLX $3.20
  • Resistance Level
  • RBOT $14.05
  • GNLX $4.23
  • Average True Range (ATR)
  • RBOT 1.30
  • GNLX 0.56
  • MACD
  • RBOT -0.09
  • GNLX 0.10
  • Stochastic Oscillator
  • RBOT 30.30
  • GNLX 95.73

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: